Press Release

We are pleased to announce the successful signing and approval of a Confidential Disclosure Agreement (CDA) between our organization and the National Institute of Pharmaceutical Education and Research (NIPER).
This milestone marks a key step toward strengthening collaboration, enabling the secure exchange of confidential information for research, development, and future business opportunities.
The agreement reflects a shared commitment to innovation, transparency, and strategic partnership. With this foundation in place, both parties will move forward with technical evaluations and collaborative initiatives.
We look forward to a strong and productive association with NIPER and will continue to share further updates.

We are pleased to announce our participation in IPPE 2026, to be held in Atlanta, GA, USA, from 27 January to 29 January 2026.

We warmly invite you to visit us at Booth No. A243 and connect with our team.

We look forward to seeing you there!We are pleased to announce our participation in IPPE 2026, to be held in Atlanta, GA, USA, from 27 January to 29 January 2026.

We warmly invite you to visit us at Booth No. A243 and connect with our team.

We look forward to seeing you there!

Pioneering Innovation in Veterinary Healthcare

We are proud to announce that we are the first Indian veterinary company to introduce the Florfenicol 5% + Trimethoprim 5% synergistic combination for Aqua Care and Poultry Care.

The company has successfully received the product license for this combination specifically for export markets. This innovative formulation has been introduced in the Gulf region, marking a significant milestone in our global expansion.

With this achievement, we are delighted to be the first Indian company to bring this unique combination product to the international market, reinforcing our commitment to innovation, quality, and global animal health solutions.